Type to search

Manufacturing & Distribution News

Delaware pharma company sues over allegedly stolen secrets

Avatar photo
Share

(AP) — A Delaware pharmaceutical company says a high-ranking scientist stole company secrets and shared them with a Silicon Valley startup.

The News-Journal reports that the company, Incyte, is accusing Jordan Fridman, a scientist who worked at the company’s headquarters for more than a decade, of feeding company secrets about a cancer-fighting drug to a prospective employer, which used the information to secure a $1.25 billion acquisition by competitor Bristol-Myers Squibb. The suit says Fridman left Incyte for Flexus Biosciences a year before Bristol-Myers Squibb acquired the company.

A lawsuit seeks damages from Flexus’s two founders and the company itself for an amount that could surpass $2 billion.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2024 Delaware Business Times

Important notice for access to your Delaware Business Times “Insider” content

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Limited time offer. New subscribers only.

SUMMER FLASH SALE!

Subscribe to Delaware Business Times and save 50%